UniQuest is the commercialisation company of The University of Queensland, founded in 1984 to transform university research into market solutions. It manages the $32M UniQuest Extension Fund, which invests in startups founded by UQ staff, students, and alumni.
Average disclosed round size is $28.6M (across 10 rounds with reported amounts).
Portfolio
7
Fund Size
$32M
Top Stage
Series C
Last 12 Mo
0
Team
AM
Andrew Morgan
Director
AB
Anne-Marie Birkill
Director
DJ
Dr Julian Clark
Director
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
14 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Lucia Bio | Seed | — | Aug 2025 |
 Earthodic | Seed | $4M | Oct 2024 |
 Vicebio | Series B | $100M | Sep 2024 |
| Earthodic | Pre-Seed | $1.9M | May 2023 |
| SSpinifex Pharmaceuticals | Unknown | $45M | Apr 2014 |
| SSpinifex Pharmaceuticals | Series C | $45M | Jan 2014 |
| SSpinifex | Series C | $45M | Jan 2014 |
| SSpinifex Pharmaceuticals | Series B | $18.3M | Aug 2011 |
| SSpinifex | Series B | $6.5M | Aug 2011 |
| SSpinifex Pharmaceuticals | Series B | — | Jan 2011 |
| NNuventix | Series C | — | Apr 2009 |
| NNuventix | Series C | $18M | Jan 2009 |
| SSpinifex Pharmaceuticals | Series A | — | Jan 2005 |
 VeriQuantix | Seed | $2.4M | — |
Top Co-Investors
Canaan Partners7 shared
Brandon Capital6 shared
Plug and Play Tech Center2 shared
Investible2 shared
FTW Ventures2 shared
Closed Loop Partners2 shared
Novo Holdings A/S2 shared
Silicon Valley Bank2 shared
Braemar Energy Ventures2 shared
Twynam1 shared
Novo Capital1 shared
Powerhouse Ventures1 shared
InterWest Partners1 shared
venBio1 shared
Avon Ventures1 shared
The Goldman Sachs Group, Inc.1 shared
Goldman Sachs Alternatives1 shared
Medicxi1 shared
TCG Crossover1 shared
Last updated: 20 October 2026